Noura S Abul-Husn, MD, PhD

img_Noura S Abul-Husn
ASSOCIATE CLINICAL PROFESSOR | Medicine, Medical Genomics
Research Topics
Clinical Genomics, Genetics, Genomics
Multi-Disciplinary Training Area
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Genetics and Genomic Sciences [GGS]

MD, Icahn School of Medicine at Mount Sinai

PhD, Icahn School of Medicine at Mount Sinai

Publications

Selected Publications

A Phenotype Risk Score–Triggered E-Visit Pathway to Capture TTR V142I in a Heart Failure Population. James W. Johnson, Deepa Sarkar, Isabelle Kornblau, Juhyun R. Baik, Melanie Besculides, Abena Gyasi, Naomi So, Noura S. Abul-Husn, Vikas Pejaver, Amy R. Kontorovich. JACC: Case Reports

Additive value of polygenic risk and family history for coronary heart disease risk stratification in two diverse US cohorts. Mohammadreza Naderian, Johanna L. Smith, Ozan Dikilitas, Marwan E. Hamed, Noura S. Abul-Husn, John J. Connolly, Josh B. Cortopassi, Qiping Feng, Sarah C. Hanks, Ryan Irvin, Gail P. Jarvik, Eimear E. Kenny, Atlas Khan, Leah C. Kottyan, Nita A. Limdi, Elizabeth M. McNally, Emily Miller, Bahram Namjou-Khales, Megan Roy-Puckelwartz, Robb Rowley, Hemant K. Tiwari, Wei Qi Wei, Georgia Wiesner, Teri A. Manolio, Richard R. Sharp, Iftikhar J. Kullo. American Journal of Human Genetics

Large-scale analysis demonstrates the influence of CYP2C19 genotype on specific SSRI side effects. Chris Eijsbouts, Yunxuan Jiang, James R. Ashenhurst, Julie M. Granka, Wanwan Xu, Catherine H. Weldon, Xin Wang, Vinh Tran, Joyce Y. Tung, Qiaojuan Jane Su, Teague Sterling, Suyash Shringarpure, Jingchunzi Shi, Anjali J. Shastri, Shubham Saini, Steve Pitts, Jared O’Connell, Carrie Northover, Alex Moran, Matthew H. McIntyre, Aly Khan, Yanyu Liang, Keng Han Lin, Alan Kwong, Katelyn Kukar Bond, Matt Kmiecik, Ethan M. Jewett, M. Reza Jabalameli, Michael V. Holmes, David A. Hinds, Barry Hicks, Larry Hengl, Chris German, Shirin Fuller, Nicholas Eriksson, Sarah L. Elson, Payam Dibaeinia, Devika Dhamija, Emily DelloRusso, Kahsaia de Brito, Sayantan Das, Zayn Cochinwala, Robert K. Bell, Stella Aslibekyan, Steven Pitts, Adam Auton, Noura S. Abul-Husn, Alison Chubb, R. Ryanne Wu. Pharmacogenomics Journal

View All Publications

Population Genomic Health: Bridging Genomics into Clinical Care

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Abul-Husn during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Inflection Medicine

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • Inflection Medicine

Outside Employment

  • 23andMe Research Institute

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.